|
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma |
|
|
|
Titel: |
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma |
Auteur: |
Kumai, Takumi Nagato, Toshihiro Kobayashi, Hiroya Komabayashi, Yuki Ueda, Seigo Kishibe, Kan Ohkuri, Takayuki Takahara, Miki Celis, Esteban Harabuchi, Yasuaki |
Verschenen in: |
Cancer, immunology, immunotherapy |
Paginering: |
Jaargang 64 (2015) nr. 6 pagina's 697-705 |
Jaar: |
2015 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|